Clinical Trial Update: Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial compares Budesonide Multimatrix (MMX) with Prednisolone for managing mild to moderate ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Budesonide Multimatrix (MMX) (budesonide multimatrix)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Assiut University | Conditions: Ulcerative Colitis Chronic | Phase 2, Phase 3 | Status: UNKNOWN